Skip to main content

Table 4 Parameters from ROC analysis on serum Trx1 levels between patients with breast and other cancers

From: Thioredoxin 1 as a serum marker for breast cancer and its use in combination with CEA or CA15-3 for improving the sensitivity of breast cancer diagnoses

Type of cancer

AUC* (±SEM)

Sensitivity (%)

Specificity (%)

Criterion (ng/ml)

BC/NMF

0.911 ± 0.0179

89.3

78.0

>32.3390

BC/CRC

0.765 ± 0.0388

88.8

58.7

>33.5024

BC/KC

0.809 ± 0.0461

75.6

76.7

>35.3212

BC/LC

0.773 ± 0.0281

89.3

55.0

>32.2963

  1. *P < 0.0001.